KETABCHI, SHEYDA
 Distribuzione geografica
Continente #
NA - Nord America 206
EU - Europa 163
AS - Asia 57
SA - Sud America 6
OC - Oceania 3
Totale 435
Nazione #
US - Stati Uniti d'America 206
IT - Italia 62
RU - Federazione Russa 53
SG - Singapore 21
HK - Hong Kong 18
SE - Svezia 17
CN - Cina 9
IE - Irlanda 9
BR - Brasile 5
FI - Finlandia 5
IN - India 5
DE - Germania 4
AU - Australia 3
CH - Svizzera 3
GB - Regno Unito 3
AT - Austria 2
FR - Francia 2
TR - Turchia 2
AR - Argentina 1
ES - Italia 1
IM - Isola di Man 1
KR - Corea 1
NL - Olanda 1
VN - Vietnam 1
Totale 435
Città #
Santa Clara 92
Florence 26
Chandler 17
Hong Kong 14
Singapore 13
Ashburn 11
Fairfield 11
Cambridge 9
Dublin 9
Houston 8
Rome 6
Woodbridge 5
Altamura 4
Lawrence 4
Moscow 4
Seattle 4
Beijing 3
Boardman 3
Melbourne 3
Milan 3
Montevarchi 3
Scandicci 3
Wilmington 3
Boston 2
Hefei 2
Izmir 2
Jacksonville 2
Mumbai 2
New York 2
Princeton 2
Pune 2
Senigallia 2
Turku 2
Vienna 2
Zurich 2
Americana 1
Ann Arbor 1
Bengaluru 1
Berlin 1
Bern 1
Birigui 1
Canarana 1
Douglas 1
Figline Valdarno 1
Hanoi 1
Helsinki 1
Hounslow 1
Kent 1
Lanús 1
London 1
Los Angeles 1
Medford 1
Mundo Novo 1
Munich 1
New Bedfont 1
Norwalk 1
Paris 1
Rio Branco 1
Romola 1
San Diego 1
Seoul 1
Sovicille 1
Stockholm 1
Washington 1
Xi'an 1
Yubileyny 1
Totale 313
Nome #
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. 138
AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report 112
MIDDLE EAR ADENOMA IS AN AMPHICRINE TUMOR: WHY CALL IT ADENOMA? 101
Pauci-immune synovitis in other inflammatory arthritides: it's not just a subtype of rheumatoid arthritis that is unresponsive to treatment 88
Totale 439
Categoria #
all - tutte 1.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 4 0 0 1 0 2 0 0 2 1 2 0
2021/202214 0 4 0 1 1 0 1 1 0 0 2 4
2022/202353 4 13 4 5 3 9 5 5 2 2 0 1
2023/202484 0 9 6 1 4 11 6 13 8 12 11 3
2024/2025230 7 24 11 33 74 40 1 10 7 4 10 9
Totale 439